A Screen Using Human Induced Pluripotent Stem Cell-Derived Hepatocytes to Identify Novel Drugs for the Treatment for Hypercholesterolemia

被引：0
|
作者：
Liu, Jui Tung
Lamprecht, Mary P.
Holshouser, Steven L.
Peterson, Yuri K.
Woster, Patrick M.
Duncan, Stephen A.
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13923
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Reply to 'Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?'
    Shiti, Assad
    Goldfracht, Idit
    Shaheen, Naim
    Protze, Stephanie
    Gepstein, Lior
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [22] Pluripotent Stem Cell-Derived Hepatocytes: Potential and Challenges in Pharmacology
    Szkolnicka, Dagmara
    Zhou, Wenli
    Lucendo-Villarin, Balta
    Hay, David C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013, 2013, 53 : 147 - 159
  • [23] CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease
    Wei, Rui
    Yang, Jiayin
    Cheng, Chi-Wa
    Ho, Wai-In
    Li, Na
    Hu, Yang
    Hong, Xueyu
    Fu, Jian
    Yang, Bo
    Liu, Yuqing
    Jiang, Lixiang
    Lai, Wing-Hon
    Au, Ka-Wing
    Tsang, Wai-Ling
    Tse, Yiu-Lam
    Ng, Kwong-Man
    Esteban, Miguel A.
    Tse, Hung-Fat
    JHEP REPORTS, 2022, 4 (01)
  • [24] Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell-Derived Hepatocytes
    Holmgren, Gustav
    Sjogren, Anna-Karin
    Barragan, Isabel
    Sabirsh, Alan
    Sartipy, Peter
    Synnergren, Jane
    Bjorquist, Petter
    Ingelman-Sundberg, Magnus
    Andersson, Tommy B.
    Edsbagge, Josefina
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (09) : 1401 - 1406
  • [25] An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes
    Chi, Huanting
    Qu, Bingqian
    Prawira, Angga
    Richardt, Talisa
    Maurer, Lars
    Hu, Jungen
    Fu, Rebecca M.
    Lempp, Florian A.
    Zhang, Zhenfeng
    Grimm, Dirk
    Wu, Xianfang
    Urban, Stephan
    Dao Thi, Viet Loan
    EMBO REPORTS, 2024, 25 (10) : 4311 - 4336
  • [26] Modeling Carfilzomib Induced Cardiotoxicity Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes
    Forghani, Parvin
    Rashid, Aysha
    Li, Dong
    Mandawat, Anant
    Xu, Chunhui
    CIRCULATION RESEARCH, 2020, 127
  • [27] Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes
    Dell'Era, Patrizia
    Benzoni, Patrizia
    Crescini, Elisabetta
    Valle, Matteo
    Xia, Er
    Consiglio, Antonella
    Memo, Maurizio
    WORLD JOURNAL OF STEM CELLS, 2015, 7 (02): : 329 - 342
  • [28] Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
    A. D. Podgurskaya
    M. M. Slotvitsky
    V. A. Tsvelaya
    S. R. Frolova
    S. G. Romanova
    V. A. Balashov
    K. I. Agladze
    Scientific Reports, 11
  • [29] Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes
    Yamazaki, Daiju
    Kitaguchi, Takashi
    Ishimura, Masakazu
    Taniguchi, Tomohiko
    Yamanishi, Atsuhiro
    Saji, Daisuke
    Takahashi, Etsushi
    Oguchi, Masao
    Moriyama, Yuta
    Maeda, Sanae
    Miyamoto, Kaori
    Morimura, Kaoru
    Ohnaka, Hiroki
    Tashibu, Hiroyuki
    Sekino, Yuko
    Miyamoto, Norimasa
    Kanda, Yasunari
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 136 (04) : 249 - 256
  • [30] In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
    Tanaka, Tomofumi
    Tohyama, Shugo
    Murata, Mitsushige
    Nomura, Fumimasa
    Kaneko, Tomoyuki
    Chen, Hao
    Hattori, Fumiyuki
    Egashira, Toru
    Seki, Tomohisa
    Ohno, Yohei
    Koshimizu, Uichi
    Yuasa, Shinsuke
    Ogawa, Satoshi
    Yamanaka, Shinya
    Yasuda, Kenji
    Fukuda, Keiichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (04) : 497 - 502
12345